Luoxin Pharmaceuticals Group Stock Co., Ltd.
SZSE:002793.SZ
5.28 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -661.138 | -1,257.986 | 421.646 | 342.601 | 653.755 | 111.346 | 115.852 | 100.363 | 81.787 | 63.959 | 45.964 | 53.666 | 32.521 |
| Depreciation & Amortization
| 222.542 | 231.306 | 199.777 | 170.598 | 154.762 | 23.445 | 21.159 | 15.429 | 10.064 | 8.402 | 8.17 | 24.795 | 0 |
| Deferred Income Tax
| 137.323 | -265.076 | -57.614 | 10.309 | -38.996 | -40.982 | 0.067 | 0.117 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | -5.564 | 5.564 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 621.683 | -9.104 | -721.163 | -703.723 | -789.955 | -22.219 | -46.354 | -29.356 | -40.838 | -44.554 | -0.133 | -116.64 | 0 |
| Accounts Receivables
| 791.712 | 689.644 | -733.092 | -483.783 | -1,023.49 | -370.67 | -45.892 | 6.933 | -196.655 | -46.5 | 37.537 | -80.854 | 0 |
| Inventory
| 168.467 | -52.036 | -70.368 | 70.787 | -4.171 | -18.289 | -32.919 | -48.892 | -17.125 | -23.201 | 12.871 | -35.786 | 0 |
| Accounts Payables
| -365.763 | -381.635 | 139.911 | -300.332 | 276.703 | -35.477 | 32.391 | 12.486 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 27.266 | -265.076 | -57.614 | 9.605 | -38.996 | -3.93 | -13.434 | 19.536 | -23.713 | -21.353 | -13.004 | 0 | 0 |
| Other Non Cash Items
| 83.049 | 96.657 | 283.551 | 142.253 | 97.768 | 1.543 | 11.618 | -13.694 | 7.109 | 14.024 | 10.752 | -53.666 | -32.521 |
| Operating Cash Flow
| 552.791 | -939.127 | 120.633 | -32.398 | 116.33 | 114.115 | 102.275 | 72.742 | 58.123 | 41.831 | 64.752 | 33.315 | 46.532 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -242.39 | -194.82 | -309.029 | -360.76 | -580.582 | -187.874 | -161.067 | -71.005 | -41.731 | -55.584 | -19.483 | -80.96 | -23.309 |
| Acquisitions Net
| 42.284 | -1.928 | -4.582 | 22.741 | -320 | -309.78 | 0.001 | 0.09 | 0.033 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -24 | -76.928 | -137.716 | -139.322 | -1,407.64 | -100 | 0 | -100 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 36.971 | 146.079 | 56.524 | 631.577 | 1,532.815 | 2.932 | 104.004 | 10.769 | 0 | 3.678 | 3.06 | 1.493 | 0 |
| Other Investing Activites
| 1,094.093 | 8.415 | -33.618 | -46.296 | 27.659 | 309.979 | 2.231 | 2.766 | 0.033 | 0.006 | 0.099 | -80.96 | 0.345 |
| Investing Cash Flow
| 906.959 | -119.182 | -428.422 | 107.941 | -747.749 | -284.744 | -54.832 | -157.38 | -41.698 | -51.901 | -16.324 | -79.468 | -22.964 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -2,233.21 | -2,246.627 | -847.372 | -775.006 | -478.693 | -72.395 | -91.335 | -195.559 | -128.457 | -111.908 | -178.641 | -31.472 | -63.065 |
| Common Stock Issued
| 0 | 40.66 | 30.139 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -40.66 | -30.139 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -76.785 | -14.947 | -54.85 | -72.355 | -59.509 | -21.36 | -60.661 | -2.458 | -61.389 | -1.991 | -2.982 | -6.925 | -25.428 |
| Other Financing Activities
| 532.509 | 2,769.87 | 1,769.237 | 1,041.801 | 1,153.811 | 458.848 | 91.335 | 353.474 | 196.332 | 120.856 | 126.121 | 84.714 | 109.687 |
| Financing Cash Flow
| -1,716.343 | 384.978 | 789.533 | 130.708 | 615.609 | 365.093 | -60.661 | 155.457 | 6.485 | 6.958 | -55.502 | 46.317 | 21.194 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 2.18 | 14.099 | -1.132 | -19.299 | 5.399 | 2.242 | -3.194 | -2.661 | 1.386 | 0.592 | -4.356 | -0.829 | -0.792 |
| Net Change In Cash
| -740.906 | -659.232 | 480.612 | 186.952 | -10.41 | 196.707 | -16.412 | 68.158 | 24.296 | -2.519 | -11.43 | -0.665 | 43.97 |
| Cash At End Of Period
| 692.899 | 834.355 | 1,493.587 | 1,012.891 | 825.939 | 319.433 | 122.726 | 139.138 | 70.98 | 46.684 | 49.203 | 60.633 | 61.298 |